purpos
studi
determin
whether
acut
pulmonari
exacerb
cystic
fibrosi
associ
nonbacteri
infect
clinic
distinguish
exacerb
eighti
exacerb
patient
studi
exacerb
associ
influenza
n
compar
associ
nonbacteri
infect
n
nonbacteri
infect
detect
n
patient
influenza
lower
score
like
seroposit
creactiv
protein
patient
two
group
patient
influenza
mean
decreas
forc
expiratori
volum
per
second
compar
test
result
obtain
exacerb
contrast
mean
decreas
forc
expiratori
volum
per
second
nonbacteri
infect
group
without
nonbacteri
infect
p
comparison
forc
expiratori
flow
first
vital
capac
decreas
influenza
group
compar
two
group
respect
p
comparison
influenza
group
also
higher
proport
patient
least
decreas
forc
expiratori
volum
per
second
forc
expiratori
flow
first
vital
capac
two
group
p
comparison
data
suggest
influenza
associ
sever
exacerb
patient
cystic
fibrosi
support
recommend
effort
prevent
influenza
popul
studi
patient
cystic
fibrosi
suggest
approxim
one
third
acut
pulmonari
exacerb
associ
nonbacteri
infect
although
incid
viral
respiratori
infect
patient
cf
compar
unaffect
children
frequent
infect
patient
may
associ
increas
rate
pulmonari
deterior
protocol
studi
approv
univers
utah
medic
center
investig
review
board
inform
consent
obtain
particip
studi
patient
seen
cf
clinic
univers
utah
medic
center
septemb
april
acut
pulmonari
exacerb
cf
elig
admiss
studi
pulmonari
exacerb
defin
acut
chang
health
associ
fever
hemoptysi
increas
dyspnea
cough
sputum
product
time
enrol
patient
histori
obtain
physic
examin
evalu
sever
underli
cf
shwachman
score
also
done
patient
also
specimen
collect
viral
bacteri
cultur
viral
serolog
studi
complet
blood
cell
count
differenti
cell
count
determin
serum
creactiv
protein
patient
old
enough
cooper
ask
particip
pulmonari
function
studi
exacerb
either
viral
cultur
acut
convalesc
serum
specimen
collect
includ
data
analysi
exacerb
four
exclud
data
analysi
specimen
avail
clinic
evalu
specif
histor
inform
physic
find
record
patient
studi
includ
presenc
upper
respiratori
tract
symptom
durat
ill
present
weight
loss
household
contact
respiratori
ill
presenc
wheez
sever
underli
diseas
assess
modifi
shwachmankulczycki
score
system
employ
brasfield
score
chest
roentgenogram
find
chest
roentgenogram
evalu
score
one
investig
pgb
pulmonari
function
test
pulmonari
function
test
done
computer
portabl
spiromet
model
cmv
cybermed
inc
lewisvil
colo
patient
ask
perform
three
consecut
forc
vital
capac
maneuv
highest
valu
record
result
pft
done
acut
exacerb
compar
studi
done
previou
month
patient
acut
ill
result
analyz
calcul
percentag
chang
baselin
test
group
patient
compar
determin
mean
percentag
chang
baselin
pft
viral
cultur
specimen
viral
cultur
obtain
within
hour
patient
enrol
studi
patient
nasopharyng
throat
specimen
obtain
calcium
algin
swab
swab
place
viral
collect
broth
earl
balanc
salt
solut
bovin
serum
albumin
supplement
penicillin
uml
streptomycin
gml
kept
c
inocul
celt
cultur
within
hour
collect
specimen
inocul
tube
cultur
human
foreskin
fibroblast
primari
cynomolgu
monkey
kidney
cell
madindarbi
canin
kidney
cell
also
inocul
winter
month
influenza
viru
preval
tube
incub
stationari
rack
c
two
tube
cultur
human
lung
fibroblast
cell
inocul
incub
roller
drum
c
isol
rhinovirus
viral
isol
identifi
standard
immunolog
virolog
method
serolog
determin
serum
specimen
obtain
within
day
enrol
studi
serum
specimen
collect
convalesc
week
enrol
test
presenc
specif
antivir
antibodi
specimen
store
c
time
collect
antibodi
assay
perform
antibodi
influenza
b
parainfluenza
type
adenoviru
respiratori
syncyti
viru
mycoplasma
pneurnonia
detect
complement
fixat
antibodi
coronaviru
detect
microtit
neutral
assay
fourfold
greater
rise
antibodi
titer
pair
serum
sampl
consid
evid
viral
mycoplasm
infect
bacteri
cultur
sputum
specimen
obtain
patient
abl
produc
adequ
sampl
young
children
abl
provid
sampl
specimen
respiratori
secret
obtain
sampl
hypopharynx
cotton
swab
specimen
inocul
onto
sheep
blood
agar
plate
incub
c
creactiv
protein
determin
concentr
crp
determin
acut
serum
specimen
obtain
time
enrol
studi
crp
assay
done
rate
nephelometri
beckman
immunochemistri
system
beckman
instrument
inc
fullerton
calif
valu
mgdl
consid
posit
statist
analysi
proport
compar
fisher
exact
test
continu
variabl
group
patient
compar
twosid
mannwhitney
u
test
statist
analys
perform
commerci
softwar
nwa
statpak
northwest
analyt
inc
portland
ore
eighti
exacerb
patient
includ
data
analysi
thirtyf
patient
one
exacerb
two
exacerb
five
three
exacerb
one
patient
four
exacerb
studi
period
patient
rang
age
month
year
mean
age
year
twentyeight
patient
male
broad
spectrum
diseas
sever
modifi
shwachman
score
rang
mean
exacerb
requir
hospit
judgment
physician
care
patient
uniform
criteria
hospit
admiss
use
two
death
occur
studi
period
viral
cultur
specimen
obtain
exacerb
pair
sera
viral
mycoplasm
serolog
studi
avail
patient
exacerb
twentythre
exacerb
associ
nbi
five
patient
posit
viral
cultur
nbi
detect
serolog
studi
tabl
three
exacerb
associ
serolog
evid
infect
two
differ
pathogen
bacteri
cultur
reveal
pulmonari
exacerb
occur
patient
colon
pseudomona
aeruginosa
patient
colon
pseudomona
cepacia
correl
colon
either
organ
detect
associ
nbi
clinic
characterist
histori
physic
examin
find
exacerb
associ
nbi
compar
find
exacerb
associ
nbi
clinic
find
two
group
similar
patient
nbi
admit
hospit
compar
patient
nbi
examin
reveal
patient
diagnosi
influenza
infect
like
admit
hospit
patient
nbi
p
mean
shwachman
score
patient
influenza
mean
sd
compar
patient
nbi
patient
nbi
p
comparison
laboratori
find
complet
blood
cell
count
done
enrol
studi
exacerb
associ
nbi
remain
exacerb
complet
blood
cell
count
similar
two
group
quantit
crp
measur
done
enrol
studi
patient
exacerb
nbi
remain
exacerb
crp
find
posit
exacerb
test
patient
nbi
posit
crp
find
compar
patient
nbi
p
six
patient
influenzaassoci
exacerb
test
posit
crp
find
compar
patient
nbi
patient
nbi
p
comparison
mean
quantit
crp
valu
higher
mgdl
patient
influenza
patient
nbi
mgdl
p
shwachman
score
significantli
lower
patient
posit
crp
find
patient
without
crp
p
associ
posit
crp
find
magnitud
declin
pulmonari
function
test
result
pulmonari
function
test
pulmonari
function
test
done
exacerb
associ
nbi
exacerb
nbi
mean
percentag
chang
pft
result
differ
significantli
two
group
pulmonari
function
test
six
eight
patient
influenza
comparison
patient
influenza
either
patient
nbi
nbi
influenza
reveal
significantli
greater
declin
forc
expiratori
volum
second
forc
expiratori
flow
first
vital
capac
patient
tabl
ii
analysi
limit
exacerb
patient
shwachman
score
less
result
comparison
except
differ
magnitud
declin
fevt
patient
influenza
compar
nbi
longer
statist
signific
data
also
analyz
compar
proport
patient
group
least
declin
result
pft
four
six
patient
influenza
patient
nbi
patient
nbi
influenza
least
declin
fevi
p
comparison
proport
patient
group
least
declin
respect
p
comparison
correl
shwachman
score
magnitud
chang
pft
result
acut
exacerb
r
r
correl
shwachman
score
chang
respect
taken
whole
pulmonari
exacerb
cf
associ
nbi
studi
gener
indistinguish
exacerb
nbi
detect
variou
nonbacteri
pathogen
howev
appear
differ
implic
pulmonari
function
exacerb
associ
influenza
viru
gener
sever
associ
nbi
nbi
detect
patient
cf
colon
lower
respiratori
tract
bacteri
pathogen
assum
play
role
pathogenesi
acut
pulmonari
exacerb
cf
although
strong
argument
made
role
recent
control
studi
detect
signific
benefit
antibiot
therapi
accept
bacteri
infect
caus
acut
exacerb
persist
assumpt
bacteri
infect
caus
exacerb
may
discourag
examin
possibl
precipit
agent
associ
viral
infect
acut
exacerb
cf
examin
sever
incid
viral
infect
patient
exacerb
predomin
viral
pathogen
influenza
parainltuenza
respiratori
syncyti
viru
studi
exacerb
associ
nbi
coronaviru
sought
previou
studi
detect
exacerb
two
control
studi
indic
incid
viral
respiratori
diseas
patient
cf
similar
healthi
children
wang
et
al
found
incid
respiratori
viral
infect
document
serolog
studi
per
patient
per
year
group
ramsey
et
al
found
incid
viral
respiratori
infect
per
patient
per
year
cf
patient
per
patient
per
year
control
subject
one
third
viral
infect
subject
cf
associ
respiratori
symptom
two
studi
allow
conclus
patient
cf
unusu
suscept
either
viral
infect
ill
caus
viral
pathogen
result
differ
regard
longterm
implic
viral
infect
wang
et
al
found
signific
associ
annual
incid
viral
infect
rate
pulmonari
diseas
progress
ramsey
et
al
unabl
confirm
observ
none
previou
studi
cf
patient
design
examin
clinic
manifest
acut
exacerb
diseas
associ
nbi
found
exacerb
associ
influenza
virus
sever
either
associ
nbi
detect
nbi
variat
clinic
manifest
pulmonari
exacerb
associ
differ
nonbacteri
pathogen
suggest
result
studi
effect
nbi
cf
need
interpret
light
specif
viral
pathogen
detect
studi
popul
serum
crp
concentr
suggest
mean
differenti
viral
bacteri
infect
correl
crp
posit
presenc
absenc
nbi
studi
glass
et
al
recent
report
serum
crp
concentr
sensit
indic
pulmonari
exacerb
patient
cf
patient
pulmonari
exacerb
definit
posit
crp
find
furthermor
unabl
demonstr
correl
crp
degre
chang
pulmonari
function
data
appear
confirm
moreton
kennedi
posit
crp
find
patient
cf
best
correl
sever
underli
diseas
determin
shwachman
score
studi
design
establish
causeandeffect
relationship
nbi
pulmonari
exacerb
cf
result
studi
howev
support
role
influenza
infect
ill
immun
prevent
influenza
influenza
b
use
amantadin
prevent
influenza
recommend
highrisk
children
whether
intens
effort
prevent
influenza
infect
patient
cf
benefici
effect
remain
determin
